Leading the way to safer medication
 Crosscheck  Recommender

Apalutamide

Description

Apalutamide is an orally administered, selective Androgen Receptor (AR) inhibitor that binds directly to the ligand-binding domain of the AR. Apalutamide treatment decreases tumor cell proliferation and increases apoptosis leading to potent antitumor activity.

ATC Classification

Code
Title
Category
L02BB05
Apalutamide
L Antineoplastic and immunomodulating agents → L02 Endocrine therapy → L02B Hormone antagonists and related agents → L02BB Anti-androgens

Trade names

Trade name
Countries

Austria Canada Cyprus France Netherlands

Product Monographs

Monograph
Type
Country
ERLEADA Film-coated tablet
MPI, EU: SmPC